Joe Ciaffoni
CEO
CEO
CEO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Indivior Pharmaceuticals, Inc. (INDV) | Chief Executive Officer | $680,114 | $18,501,214 |
Executive changes
Earnings-call appearances
-
2026 Jefferies Global Healthcare Conference2026-06-03
Indivior Pharmaceuticals, Inc. (INDV)
-
Collegium Pharmaceutical, Inc Q3 FY2023 Earnings Call2023-11-07
Collegium Pharmaceutical, Inc (COLL)
-
Collegium Pharmaceutical, Inc Q2 FY2023 Earnings Call2023-08-03
Collegium Pharmaceutical, Inc (COLL)
-
Collegium Pharmaceutical, Inc Q1 FY2023 Earnings Call2023-05-04
Collegium Pharmaceutical, Inc (COLL)
-
Collegium Pharmaceutical, Inc Q4 FY2022 Earnings Call2023-02-23
Collegium Pharmaceutical, Inc (COLL)
-
Collegium Pharmaceutical, Inc Q3 FY2022 Earnings Call2022-11-03
Collegium Pharmaceutical, Inc (COLL)
-
Collegium Pharmaceutical, Inc Q1 FY2022 Earnings Call2022-05-10
Collegium Pharmaceutical, Inc (COLL)
-
Collegium Pharmaceutical, Inc Q4 FY2021 Earnings Call2022-02-24
Collegium Pharmaceutical, Inc (COLL)
-
Collegium Pharmaceutical, Inc Q3 FY2021 Earnings Call2021-11-04
Collegium Pharmaceutical, Inc (COLL)
-
Collegium Pharmaceutical, Inc Q1 FY2021 Earnings Call2021-05-06
Collegium Pharmaceutical, Inc (COLL)
-
Collegium Pharmaceutical, Inc Q4 FY2020 Earnings Call2021-02-25
Collegium Pharmaceutical, Inc (COLL)
-
Collegium Pharmaceutical, Inc Q1 FY2020 Earnings Call2020-05-07
Collegium Pharmaceutical, Inc (COLL)